Furthermore, ARRB2 was highly expressed in N1 and TP53-nonmutant groups compared with N0 and TP53-mutant, suggesting that the level of this gene increased with tumor progression (Figures 2(c) and 2(d)). Here, ARRB2 is linked to neoplasm.